Bioactivity:

Ambrisentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically ap

CAS nr:

177036-94-1

Purity:

98%

Molecular Weight:

378,42

SMILES:

COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1

Formula:

C22H22N2O4

Pathway:

GPCR/G Protein

Target:

Endothelin Receptor